Authorities in China have found the novel coronavirus on the packaging of imported frozen seafood that arrived from the port city of Dalian, which recently battled a surge of cases, a local government said on Tuesday. The virus was found on the outer packaging of frozen seafood bought by three companies in Yantai, a port city in eastern Shandong province. The Yantai city government said in a statement the seafood was from an imported shipment that landed at Dalian but did not say where it originated.
- PoliticsMarie Claire
The powerhouse couple said "I do" in 2014.
Pippa Middleton Reluctantly Invited Meghan Markle to Her Wedding, Was Afraid She Would 'Overshadow' Her
Harry and Meghan decided she shouldn't attend the ceremony at the last-minute, 'Finding Freedom' reveals. Here's why.
- PoliticsBusiness Insider
Fox News host baselessly claims that 'something's going to happen' to Joe Biden, forcing her colleague to walk her comment back
"I have a sense that something's going to happen before the election, and he's not even going to be on the ticket," she said.
Hertz is selling almost 200,000 cars in bankruptcy, and it doesn't take much money to land in an almost new car.From Autoweek
"I should have sent a text. I didn't and I think that's where I feel really bad, because you would have warned me," Lisa Rinna told Denise Richards on Real Housewives of Beverly Hills
- WorldThe Week
Since the early days of the coronavirus pandemic, the United States has emphasized ratcheting up vaccine production even before federal approval so that, if and when the time comes, the stockpile is ready to go. The same can't be said about a potential treatment known as monoclonal antibodies, however, Stat News reports.Monoclonal antibodies are pretty much what they sound like — antibodies that have been genetically engineered into new medicines. Immunologists and virologists are reportedly optimistic they could play a role in fighting COVID-19, and data from two separate clinical trials run by Regeneron Pharmaceuticals and Eli Lilly are expected to be released in the fall, possibly indicating whether the therapies are safe and effective.But even if they are, it may be too late. Former Food and Drug Administration Commissioner Scott Gottlieb said the U.S. "may have a missed a window" to scale up production of the treatments, which otherwise "could have been an important bridge to a vaccine." Perhaps more importantly, he added, they could also serve as a "hedge in the event vaccines are delayed or don't work." Ultimately, despite the antibodies' potential to change the tides of the pandemic, Gottlieb said, "we just don't have enough doses to realize that goal." Read more at Stat News.More stories from theweek.com Trump has pretty much eliminated daily intelligence briefings. Biden has already started receiving them. The case against American truck bloat Kamala Harris hammers Trump's coronavirus 'failure' in 1st speech as VP candidate